XML 56 R17.htm IDEA: XBRL DOCUMENT v2.4.1.9
NOTE 11 - STOCK COMPENSATION PLANS
12 Months Ended
Dec. 27, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
NOTE 11 - STOCK COMPENSATION PLANS

In June 2009, the Company's stockholders approved a new 2009 Equity Incentive Plan (the “Equity Plan,” or the “Plan”) that provides for the issuance of up to 480,000 shares of common stock. The Equity Plan provides for grants of non-statutory options, incentive stock options, restricted stock awards, performance shares, performance units, restricted stock units and other stock-based awards, in order to enhance the ability of ENGlobal to motivate current employees, to attract employees of outstanding ability and to provide for grants to be made to non-employee directors. Grants to employees will generally vest over a four-year period, one-fourth at December 31 of each year until they are fully vested. Grants to non-employee directors will vest quarterly over a one-year period coinciding with their service term.  On April 26, 2012, the Board approved, and the stockholders subsequently approved, an amendment to the Plan to increase the number of shares available for issuance under the Plan by 500,000 from 480,000 to 980,000.  On October 20, 2013 the Board approved, and the stockholders subsequently approved, an amendment to the Plan to increase the number of shares available for issuance under the Plan by 850,000 from 980,000 to 1,830,000.

Stock Options - The Company did not grant any stock options in 2014 or 2013.  The following table summarizes activity for the period December 29, 2012 through December 27, 2014:

   
Vested and Exercisable Balance
   
Number of Shares Outstanding
   
Weighted Average Exercise Price
 
Balance at December 29, 2012
   
628,000
     
628,000
     
7.26
 
Canceled or expired
   
(78,000
)
   
(78,000
)
   
8.18
 
Balance at December 28, 2013
   
550,000
     
550,000
     
6.37
 
Exercised
   
(40,000
)
   
(40,000
)
   
1.81
 
Canceled or expired
   
(40,000
   
(40,000
   
2.32
 
Balance at December 27, 2014
   
470,000
     
470,000
     
8.01
 

The following table summarizes information concerning outstanding and exercisable Company stock options at December 27, 2014:

Exercise
Prices *
   
Options Outstanding
   
Average Remaining Contractual Life
(in years)
   
Options Fully-Vested and Exercisable
 
$
3.75
     
150,000
     
0.5
     
150,000
 
$
9.15
     
150,000
     
1.4
     
150,000
 
$
10.93
     
150,000
     
2.5
     
150,000
 
$
9.44
     
20,000
     
3.2
     
20,000
 
         
470,000
             
470,000
 

* The exercise price indicates the market value at grant date and is the strike price at exercise.

For each series, the exercise price is the weighted average exercise price of the series.

Restricted Stock Awards - Restricted stock awards granted to directors are intended to compensate and retain the directors over the one-year service period commencing July 1 of the year of service. These awards will vest in quarterly installments beginning September 30 of the year of service, so long as the grantee continues to serve as a director of the Company. Restricted stock awards granted to employees will vest in four equal annual installments on the date of grant, so long as the grantee remains employed full-time with the Company as of each vesting date. The following is a summary of the Company's restricted stock awards for the years ended December 27, 2014 and December 28, 2013:

   
Number of restricted shares
   
Weighted- average fair value
 
Unvested restricted shares at December 29, 2012
   
167,206
     
0.86
 
Granted in 2013
   
     
 
Vested in 2013
   
(50,336
)
   
1.49
 
Forfeited in 2013
   
     
 
Unvested restricted shares at December 28, 2013
   
116,870
   
$
0.59
 
Granted in 2014
   
652,481
     
1.74
 
Vested in 2014
   
(273,119
)
   
1.54
 
Forfeited in 2014
   
(43,309
)
   
1.64
 
Unvested restricted shares at December 27, 2014
   
452,923
   
$
1.57
 

The total fair value of the restricted stock that vested in the years ended December 27, 2014 and December 28, 2013 was $115,000 and $39,000, respectively. The weighted-average remaining life of restricted stock awards outstanding at December 28, 2014 was 2.52 years.  No restricted stock awards were granted in 2013.  During 2014, the Company granted restricted stock awards per the following table.

Date Issued
 
Issued to
   
Number of Shares
 
Market Price
 
Fair Value
January 8, 2014
 
Directors (3)
   
93,750
   
$
1.60
   
$
150,000
 
January 8, 2014
 
Employees (19)
   
500,000
   
$
1.60
   
$
800,000
 
April 23, 2014
 
Employee (1)
   
15,000
   
$
2.22
   
$
33,300
 
June 19, 2014
 
Directors (3)
   
43,731
   
$
3.43
   
$
150,000
 

Compensation Expense - The Company recognizes stock compensation expense relating to share-based payments in net income using the fair-value measurement method. Under the fair value method, the estimated fair value of awards is charged to expense over the requisite service period, which is generally the vesting period.  We estimate the volatility of our stock price by using historical volatility looking back 156 weeks. The expected term of options granted has been derived from the simplified method, due to changes in vesting terms and contractual lives of current options compared to our historical grants. We base the estimate of the risk-free interest rate on the United States Treasury zero-coupon yield curve in effect at the time of grant. We have never paid cash dividends and do not currently intend to pay cash dividends; accordingly, we have assumed a 0% dividend yield.

The Company recognized non-cash compensation expense related to its stock compensation plans of $0.4 million and $0.2 million for the fiscal years ended December 27, 2014 and December 28, 2013, respectively. As of December 27, 2014, unrecognized compensation expense was approximately $0.6 million. The weighted average period over which total compensation related to stock options and restricted stock awards are expected to be recognized is approximately 32 months.